OmiX Labs


Discovery Award Winner

About this entry

OmiX Labs is developing a molecular diagnostic platform and AMR signature assays that can be used to detect susceptibility to existing and repurposed antibiotics. Using OmiX's proprietary amplification technology, a culture free rapid test is being developed for detection of genes to identify the organisms and predict susceptibility.

If you would like to be introduced to this team for collaboration, get in touch with the Longitude prize.